Viewing Study NCT02146469


Ignite Creation Date: 2025-12-24 @ 11:04 PM
Ignite Modification Date: 2025-12-25 @ 8:34 PM
Study NCT ID: NCT02146469
Status: UNKNOWN
Last Update Posted: 2014-05-23
First Post: 2014-05-21
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Study on Effectiveness of 2-dose Live Attenuated Varicella Vaccine
Sponsor: Shanghai Municipal Center for Disease Control and Prevention
Organization:

Study Overview

Official Title: Study on Effectiveness of 2-dose Live Attenuated Varicella Vaccine
Status: UNKNOWN
Status Verified Date: 2014-05
Last Known Status: ENROLLING_BY_INVITATION
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The objective of the study is as follows:

1. To know the antibody level during different interval after received 1 dose varicella vaccine.
2. To know safety and effectiveness of received 2 doses varicella vaccine with different interval.
3. To know safety and effectiveness of received varicella vaccine and MMR at the same time.

To achieve that, this study selects children with specific varicella vaccine history, gives 1 or 2 doses varicella vaccine, collects blood specimens and makes a follow-up visit after vaccination.

All blood specimens will be tested by a third-party detection institution.
Detailed Description: None

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: